OS Therapies Incorporated
OSTX
$2.00
$0.189.89%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.03% | -84.60% | -6.75% | 0.38% | 25.84% |
| Total Depreciation and Amortization | -- | -100.00% | 0.00% | -- | -100.00% |
| Total Amortization of Deferred Charges | -100.00% | -33.50% | -12.10% | 171.44% | -78.27% |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 136.96% | -608.03% | -29.81% | -37.45% | 233.51% |
| Cash from Operations | 29.85% | -284.11% | -37.32% | 26.34% | 0.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | 5.76% | -20.47% | 29.70% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 814.11% | 83.72% | 15.86% | -1,055.98% |
| Cash from Financing | 17.52% | 487.74% | 24.59% | -21.37% | 6.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.45% | 33,367.92% | -108.66% | 167.25% | 168.98% |